Skip to content
Partners

Partners

Firebrick-Partners

Our partnering strategy

Firebrick Pharma is an Australian-born company with a strong international focus. With solid global licensing and distribution partnerships already in place in some territories, as well as robust relationships and exploration in others, we are continuing to actively pursue appropriate licensing partners to support the registration of Nasodine in all major countries.

Our licensing and distribution partners are market leaders in their territory with strong regulatory and distribution capabilities together with solid established marketing experience.

For all partnership enquiries please contact our team.

Our partners

Map Image
Columbia
Israel
New Zealand
Panama
Philippines
Sub-Saharan Africa

Who we work with

douglas
DOUGLAS PHARMACEUTICALS

New Zealand

Douglas Pharmaceuticals is New Zealand's largest privately owned pharmaceutical company with an ever-expanding footprint into global markets. Douglas Pharma has a relentless focus on making a positive difference in healthcare outcomes for people across the globe. Working with innovative partners to research & develop, manufacture, market and distribute prescription and over-the-counter pharmaceutical, nutraceutical, automated compliance systems and consumer healthcare products.

SV-Pharmaceuticals
SV MORE PHARMACEUTICALS

Philippines

S.V. More Group of Companies is a 100% Filipino-owned pharmaceutical marketing firm with over 30 years of unwavering commitment to provide high quality, cost effective, and reliable health products that every Filipino family deserves. S.V. More Group with its 3 parent companies and 7 distributing companies, has operations spanning the entire Philippine Archipelago to ensure that reliable and value-driven health products are within reach of all Filipinos.

adcock
ADCOCK INGRAM

South Africa & Sub Saharan African countries

Adcock Ingram is a leading South African pharmaceutical manufacturer listed on the Johannesburg Stock Exchange. Adcock Ingram is ranked as the second largest manufacturer in the private pharmaceutical market and is the second largest supplier to the public sector in South Africa and several countries in sub–Saharan Africa. Of note is the major share of the critical care market held by the company, being the largest supplier of critical care products to the public sector and hospitals. The business is a fully integrated operation which spans regulatory, manufacturing, marketing, sales and distribution.